Who owns Mirati Therapeutics?
- CUSIP Number: 60468t955
Tip: Access positions for across all investors
Analyze quarterly positions in Mirati Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mirati Therapeutics stock
Who bought or sold Mirati Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Picton Mahoney Asset Management | 199k | $997.000000 | 100% | Dec 2023 |
|
| Jane Street | 61k | $3.6M | 340% | Dec 2023 |
|
| Maven Securities | 55k | $3.2M | 100% | Dec 2023 |
|
Who sold out of Mirati Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Simplex Trading | Dec 2023 | 79k | $4.6M |